These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10542098)

  • 1. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
    Mongkolsapaya J; Grimes JM; Chen N; Xu XN; Stuart DI; Jones EY; Screaton GR
    Nat Struct Biol; 1999 Nov; 6(11):1048-53. PubMed ID: 10542098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of molecular recognition learned from the crystal structures of TRAIL and the TRAIL:sDR5 complex.
    Cha SS; Song YL; Oh BH
    Vitam Horm; 2004; 67():1-17. PubMed ID: 15110168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.
    van der Sloot AM; Tur V; Szegezdi E; Mullally MM; Cool RH; Samali A; Serrano L; Quax WJ
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8634-9. PubMed ID: 16731632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.
    Koornstra JJ; Jalving M; Rijcken FE; Westra J; Zwart N; Hollema H; de Vries EG; Hofstra RW; Plukker JT; de Jong S; Kleibeuker JH
    Eur J Cancer; 2005 May; 41(8):1195-202. PubMed ID: 15911244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
    Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
    Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between sensitivity to TRAIL and expression level of DR5 on surface of tumor cells].
    Ma YF; Zhang J; Zhao YP; Yang DL; Chen YH
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):528-30. PubMed ID: 15555281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
    Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
    J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
    Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway.
    He Q; Lee DI; Rong R; Yu M; Luo X; Klein M; El-Deiry WS; Huang Y; Hussain A; Sheikh MS
    Oncogene; 2002 Apr; 21(17):2623-33. PubMed ID: 11965535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
    Jung EM; Park JW; Choi KS; Park JW; Lee HI; Lee KS; Kwon TK
    Carcinogenesis; 2006 Oct; 27(10):2008-17. PubMed ID: 16613838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Gong B; Almasan A
    Cancer Res; 2000 Oct; 60(20):5754-60. PubMed ID: 11059770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
    Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine 230 modulates tumor necrosis factor-related apoptosis-inducing ligand activity.
    Seol DW; Billiar TR
    Cancer Res; 2000 Jun; 60(12):3152-4. PubMed ID: 10866303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae.
    Martin S; Phillips DC; Szekely-Szucs K; Elghazi L; Desmots F; Houghton JA
    Cancer Res; 2005 Dec; 65(24):11447-58. PubMed ID: 16357153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.